120 related articles for article (PubMed ID: 7627849)
21. Induction of drug resistance to gold sodium thiomalate in a monocyte cell line, THP-1.
Ichibangase Y; Yamamoto M; Yasuda M; Houki N; Nobunaga M
Clin Rheumatol; 1998; 17(3):214-8. PubMed ID: 9694055
[TBL] [Abstract][Full Text] [Related]
22. Augmented expression of metallothionein and glutathione S-transferase pi as unfavourable prognostic factors in cisplatin-treated ovarian cancer patients.
Surowiak P; Materna V; Kaplenko I; Spaczyński M; Dietel M; Lage H; Zabel M
Virchows Arch; 2005 Sep; 447(3):626-33. PubMed ID: 15968547
[TBL] [Abstract][Full Text] [Related]
23. Role of glutathione, glutathione S-transferases and multidrug resistance-related proteins in cisplatin sensitivity of head and neck cancer cell lines.
Welters MJ; Fichtinger-Schepman AM; Baan RA; Flens MJ; Scheper RJ; Braakhuis BJ
Br J Cancer; 1998 Feb; 77(4):556-61. PubMed ID: 9484811
[TBL] [Abstract][Full Text] [Related]
24. Glutathione S-transferase and multidrug-resistant phenotype in transitional cell carcinoma of the bladder.
Akdaş A; Türkeri LN; Küllü S; Tarcan T; Sakr W; Grignon DJ
Eur Urol; 1996; 29(4):483-6. PubMed ID: 8791059
[TBL] [Abstract][Full Text] [Related]
25. Metallothionein expression and resistance to cisplatin in a human germ cell tumor cell line.
Koropatnick J; Kloth DM; Kadhim S; Chin JL; Cherian MG
J Pharmacol Exp Ther; 1995 Dec; 275(3):1681-7. PubMed ID: 8531144
[TBL] [Abstract][Full Text] [Related]
26. Parallel assessment of glutathione-based detoxifying enzymes, O6-alkylguanine-DNA alkyltransferase and P-glycoprotein as indicators of drug resistance in tumor and normal lung of patients with lung cancer.
Oberli-Schrämmli AE; Joncourt F; Stadler M; Altermatt HJ; Buser K; Ris HB; Schmid U; Cerny T
Int J Cancer; 1994 Dec; 59(5):629-36. PubMed ID: 7960235
[TBL] [Abstract][Full Text] [Related]
27. Non-P-glycoprotein-mediated atypical multidrug resistance in a human bladder cancer cell line.
Naito S; Hasegawa S; Yokomizo A; Koga H; Kotoh S; Kuwano M; Kumazawa J
Jpn J Cancer Res; 1995 Nov; 86(11):1112-8. PubMed ID: 8567404
[TBL] [Abstract][Full Text] [Related]
28. Glutathione-linked detoxification pathway in normal and malignant human bladder tissue.
Singh SV; Xu BH; Tkalcevic GT; Gupta V; Roberts B; Ruiz P
Cancer Lett; 1994 Feb; 77(1):15-24. PubMed ID: 8162559
[TBL] [Abstract][Full Text] [Related]
29. Characteristics of the glutathione/glutathione-S-transferase detoxification system in melphalan resistant human prostate cancer cells.
Ripple M; Mulcahy RT; Wilding G
J Urol; 1993 Jul; 150(1):209-14. PubMed ID: 8510259
[TBL] [Abstract][Full Text] [Related]
30. Establishment and characterization of doxorubicin-resistant human bladder cancer cell line, KK47/ADM.
Kimiya K; Naito S; Soejima T; Sakamoto N; Kotoh S; Kumazawa J; Tsuruo T
J Urol; 1992 Aug; 148(2 Pt 1):441-5. PubMed ID: 1353119
[TBL] [Abstract][Full Text] [Related]
31. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance.
Xu BH; Gupta V; Singh SV
Arch Biochem Biophys; 1994 Jan; 308(1):164-70. PubMed ID: 8311448
[TBL] [Abstract][Full Text] [Related]
32. Comparison of glutathione S-transferase activity between drug-resistant and -sensitive human tumor cells: is glutathione S-transferase associated with multidrug resistance?
Yusa K; Hamada H; Tsuruo T
Cancer Chemother Pharmacol; 1988; 22(1):17-20. PubMed ID: 3396143
[TBL] [Abstract][Full Text] [Related]
33. Expression of resistance-related proteins in tumoral and peritumoral tissues of patients with lung cancer.
Koomägi R; Stammler G; Manegold C; Mattern J; Volm M
Cancer Lett; 1996 Dec; 110(1-2):129-36. PubMed ID: 9018091
[TBL] [Abstract][Full Text] [Related]
34. Do glutathione and related enzymes play a role in drug resistance in small cell lung cancer cell lines?
Campling BG; Baer K; Baker HM; Lam YM; Cole SP
Br J Cancer; 1993 Aug; 68(2):327-35. PubMed ID: 8102244
[TBL] [Abstract][Full Text] [Related]
35. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
Mizutani Y; Yoshida O; Bonavida B
J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
[TBL] [Abstract][Full Text] [Related]
36. Cisplatin-resistant bladder carcinoma cells: enhanced expression of metallothioneins.
Siegsmund MJ; Marx C; Seemann O; Schummer B; Steidler A; Toktomambetova L; Köhrmann KU; Rassweiler J; Alken P
Urol Res; 1999 Jun; 27(3):157-63. PubMed ID: 10422815
[TBL] [Abstract][Full Text] [Related]
37. Augmentation of cisplatin sensitivity in cisplatin-resistant human bladder cancer cells by modulating glutathione concentrations and glutathione-related enzyme activities.
Byun SS; Kim SW; Choi H; Lee C; Lee E
BJU Int; 2005 May; 95(7):1086-90. PubMed ID: 15839938
[TBL] [Abstract][Full Text] [Related]
38. Expression of P-glycoprotein and metallothionein in gastrointestinal stromal tumor and leiomyosarcomas. Clinical implications.
Pérez-Gutiérrez S; González-Cámpora R; Amérigo-Navarro J; Beato-Moreno A; Sánchez-León M; Pareja Megía JM; Virizuela-Echaburu JA; López-Beltrán A
Pathol Oncol Res; 2007; 13(3):203-8. PubMed ID: 17922049
[TBL] [Abstract][Full Text] [Related]
39. The prognostic role of p53, metallothionein, P-glycoprotein, and MIB-1 in muscle-invasive urothelial transitional cell carcinoma.
Siu LL; Banerjee D; Khurana RJ; Pan X; Pflueger R; Tannock IF; Moore MJ
Clin Cancer Res; 1998 Mar; 4(3):559-65. PubMed ID: 9533522
[TBL] [Abstract][Full Text] [Related]
40. Role of metallothionein in cisplatin sensitivity of germ-cell tumours.
Meijer C; Timmer A; De Vries EG; Groten JP; Knol A; Zwart N; Dam WA; Sleijfer DT; Mulder NH
Int J Cancer; 2000 Mar; 85(6):777-81. PubMed ID: 10709094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
